Canaccord Genuity Maintains Hold on T2 Biosystems, Lowers Price Target to $3
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Kyle Mikson maintains a Hold rating on T2 Biosystems (NASDAQ:TTOO) and lowers the price target from $12 to $3.
April 29, 2024 | 2:42 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Canaccord Genuity maintains a Hold rating on T2 Biosystems, with a significant reduction in price target from $12 to $3.
The substantial decrease in the price target from $12 to $3 by a reputable analyst firm like Canaccord Genuity could negatively impact investor sentiment towards T2 Biosystems in the short term, likely leading to a decrease in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100